A version of this post appeared in STAT’s Morning Rounds newsletter, a daily dose of news in health and medicine. Sign up for the newsletter here.

Scientists have discovered that cancer cells can release tiny weapons called exosomes that target immune cells before they have a chance to reach a tumor.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Paywalls are inappropriate for news items on facebook. Science thrives on open platforms. If you open source the usage via third party literature retrieval will shoot up.

  • This news is something that we could have ever known about, until we were able to read the outcome of the research that has been replicated by others time and time again. Long ago the colleagues that were in our programs at the medical school where such hypotheses were not as invested in by the medical community of research. Primarily because at that time most hospitals and medical schools were focused on their becoming the premier place to be for heart procedures that seemingly dominated the organizations with which I was familiar, during those times, in the primary focus on the heart and lung diseases, and the transplant experience that they were known for as being the hospital to go to with that topic, which dominated the almost entire medical research of heart and respiratory diseases.

    With this approach to discovery of just what could be treated successfully, is another opportunity for those of us who have been afflicted with the very same diseases that this current topic has been addressed as successful beyond what has ever been up to the current era. Exciting and filled with the hope of continued success with every single experiment that confirms the outcome data as successful.

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy